Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • bridgelight bridgelight Mar 4, 2013 5:25 AM Flag

    BLFS – the most advanced company for biopreservation media products!

    Zacks small-cap research - Demand for biopreservation media is estimated to grow at an
    annual rate of almost 20% over the next several years,
    largely driven by rapid growth of the emerging field of
    regenerative medicine (including cell therapy and tissue
    engineering, according to MedMarket Diligence . Another study, from Visiongain, also supports a robust outlook for regenerative medicine and predicts this market
    will grow from $1.4 billion in 2012 to $10 billion in 2020 (~28% CAGR).
    BioLife expects to benefit from the emerging field of regenerative medicine and is positioning their HypoThermosol and CryoStor products as a better
    alternative to other branded biopreservation media and home-brews.

    Sentiment: Buy

 
CLDX
6.84-0.42(-5.79%)Feb 8 4:00 PMEST